Skip to content

A Randomized Comparison of Posterior Lumbar Plexus, Suprainguinal Fascia Iliaca and Femoral Nerve Blocks for Postoperative Analgesia in Hip Fracture Surgery

A Randomized Comparison of Posterior Lumbar Plexus, Suprainguinal Fascia Iliaca and Femoral Nerve Blocks for Postoperative Analgesia in Hip Fracture Surgery

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20180806002
Enrollment
135
Registered
2018-08-06
Start date
2018-07-31
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture surgery Postoperative pain control Lumbar plexus block Fascia iliaca block Femoral nerve block Hip fracture surgery Postoperative pain control Lumbar plexus block Fascia iliaca block Femoral nerve block

Interventions

Target: Posteromedial quadrant of psoas muscle at L3&#45
L4 transverse process level under ultrasound guidance,Target: Under abdominal muscle and fascia iliaca&#44
above iliacus muscle under ultrasound guidance,Target: Under femoral nerve at the prebifurcation level of femoral artery under ultrasound guidance
Posterior lumbar plexus block,Supra&#45
inguinal fascia iliaca block,Femoral nerve block

Sponsors

Chiang Mai University
Lead Sponsor
Chiang Mai University
Collaborator

Eligibility

Sex/Gender
All
Age
55 Years to 0 Years

Inclusion criteria

Inclusion criteria: Patients undergoing hip fracture repair using dynamic hip screws (DHS) and intramedullary hip screws (IMHS).

Exclusion criteria

Exclusion criteria: - Previous hip surgery - Inability to understand and report pain severity - Decreased mental status or confusion state - Uncontrolled cardiovascular and respiratory diseases - Hepatic or renal failure - Chronic opioids use - Allergy to levobupivacaine or other medications used in the protocol - Contraindications for spinal anesthesia: patient refusal, coagulopathy, increased intracranial pressure, local skin infection at needle insertion site, preload- and afterload-dependent cardiovascular disease (eg. aortic stenosis), intravascular volume depletion, sepsis, abnormal spine anatomy - Contraindications for all PNBs: patient refusal, preexisting neurological deficit, abnormal anatomy of back or inguinal area

Design outcomes

Primary

MeasureTime frame
24-hour morphine consumption start at PACU until 24 hours after the end of operation total dose of intravenous morphine administration within 24 hours after operation

Secondary

MeasureTime frame
Postoperative pain scores Start at PACU and every 4 hours until 24 hours after the end of operation Verbal rating scale (0-4),Positioning time Start at placing a patient for anesthetic procedure until finish positioning Time (seconds) used for patient's positioning,Complications of peripheral nerve blocks start at operating room until 24 hours after the end of operation Incidences of vascular puncture, paresthesia, LA toxicity,Complications of surgery Start at operating room until 24 hours after the end of operation Incidences of bleeding, thromboembolic event, re-operation,Postioperative physiotherapy Start at PACU until 7 days after the end of operation Postoperative day that a patient starts walking

Countries

Thailand

Contacts

Public ContactPrangmalee Leurcharusmee

Chiang Mai University

prangmalee.l@cmu.ac.th0897592647

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026